Pathologic changes associated with androgen deprivation therapy for prostate cancer
Open Access
- 15 August 1991
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters events that accompany tumor regressionCancer, 1990
- New Staging Systems for Prostate CancerJournal of Urology, 1989
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Serum prostate-antigen levels in patients with benign prosttic hypertrophy treated with leuprolideUrology, 1989
- Incidental Carcinoma of the Prostate How Much Sampling is Adequate?The American Journal of Surgical Pathology, 1986
- Treatment of Prostate Cancer with Gonadotropin-Releasing Hormone AgonistsEndocrine Reviews, 1986
- Comparison of leuprolide and diethylstilbestrol for stage D2 adenocarcinoma of prostateUrology, 1985
- Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapyThe Prostate, 1985
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical StagingJournal of Urology, 1974